Barclays Bank (GRN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $34.31, -0.33% vs the prior close of $34.42.
- Volume 606 shares, 1.1x its 50-day average.
- New SEC filings: 424B2 (Oct 19, 2026), 424B2 (Oct 19, 2026), 424B2 (Oct 19, 2026), 424B2 (Oct 19, 2026), 424B2 (Oct 19, 2026), 424B2 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
GRN dips 0.3% to $34.31, 3 down days in a row. Closed at $34.31, -0.33% vs the prior close of $34.42. Day range $34.31β$34.31, opened at $34.00.
GRN daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β GRN dips 0.3% to $34.31, 3 down days in a row
- Closed at $34.31, -0.33% vs the prior close of $34.42. Day range $34.31β$34.31, opened at $34.00.
- Volume was 606 shares, 1.1x its 50-day average of 536.
- Price is +1.4% vs its 50-day average ($33.82) and +9.0% vs its 200-day average ($31.49).
- 52-week range $25.02β$36.45; today's close sits at 81% of that range, 5.9% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 β GRN dips 1.1% to $34.42
- Closed at $34.42, -1.06% vs the prior close of $34.79. Day range $34.42β$34.42, opened at $34.42.
- Volume was 100 shares, 0.2x its 50-day average of 536 β lighter than usual.
- Price is +1.9% vs its 50-day average ($33.79) and +9.3% vs its 200-day average ($31.49).
- 52-week range $25.02β$36.45; today's close sits at 82% of that range, 5.6% below the 52-week high.
Oct 14, 2026 β GRN dips 1.5% to $34.79
- Closed at $34.79, -1.48% vs the prior close of $35.32. Day range $34.79β$34.81, opened at $34.81.
- Volume was 300 shares, 0.6x its 50-day average of 532 β lighter than usual.
- Price is +3.1% vs its 50-day average ($33.75) and +10.5% vs its 200-day average ($31.49).
- 52-week range $25.02β$36.45; today's close sits at 86% of that range, 4.5% below the 52-week high.
Oct 13, 2026 β GRN rises 0.4% to $35.32, a 6-month high, 7 up days in a row
- Closed at $35.32, +0.45% vs the prior close of $35.16. Day range $35.32β$35.42, opened at $35.32.
- Volume was 300 shares, 0.6x its 50-day average of 530 β lighter than usual.
- Price is +4.8% vs its 50-day average ($33.70) and +12.2% vs its 200-day average ($31.48).
- 52-week range $25.02β$36.45; today's close sits at 90% of that range, 3.1% below the 52-week high.
- That makes 7 straight gains.
Oct 12, 2026 β GRN rises 0.8% to $35.16, 6 up days in a row
- Closed at $35.16, +0.80% vs the prior close of $34.88. Day range $35.16β$35.16, opened at $35.16.
- Volume was 100 shares, 0.2x its 50-day average of 530 β lighter than usual.
- Price is +4.5% vs its 50-day average ($33.64) and +11.7% vs its 200-day average ($31.48).
- 52-week range $25.02β$36.45; today's close sits at 89% of that range, 3.5% below the 52-week high.
- That makes 6 straight gains.
Oct 9, 2026 β GRN ends flat (+0.2%) to $34.88, 5 up days in a row
- Closed at $34.88, +0.19% vs the prior close of $34.81. Day range $34.72β$34.88, opened at $34.72.
- Volume was 300 shares, 0.6x its 50-day average of 526 β lighter than usual.
- Price is +3.9% vs its 50-day average ($33.58) and +10.8% vs its 200-day average ($31.48).
- 52-week range $25.02β$36.45; today's close sits at 86% of that range, 4.3% below the 52-week high.
- That makes 5 straight gains.
Oct 8, 2026 β GRN rises 1.6% to $34.81, 4 up days in a row
- Closed at $34.81, +1.63% vs the prior close of $34.26. Day range $34.79β$34.81, opened at $34.79.
- Volume was 300 shares, 0.6x its 50-day average of 528 β lighter than usual.
- Price is +3.8% vs its 50-day average ($33.54) and +10.6% vs its 200-day average ($31.47).
- 52-week range $25.02β$36.45; today's close sits at 86% of that range, 4.5% below the 52-week high.
- That makes 4 straight gains.
Oct 7, 2026 β GRN rises 1.1% to $34.26, 3 up days in a row
- Closed at $34.26, +1.05% vs the prior close of $33.90. Day range $34.26β$34.26, opened at $34.26.
- Volume was 100 shares, 0.2x its 50-day average of 528 β lighter than usual.
- Price is +2.3% vs its 50-day average ($33.49) and +8.9% vs its 200-day average ($31.47).
- 52-week range $25.02β$36.45; today's close sits at 81% of that range, 6.0% below the 52-week high.
- That makes 3 straight gains.
Oct 6, 2026 β GRN rises 1.2% to $33.90 on 11.9x normal volume
- Closed at $33.90, +1.25% vs the prior close of $33.48. Day range $33.79β$33.93, opened at $33.81.
- Volume was 5.10K shares, 11.9x its 50-day average of 428 β unusually heavy trading.
- Price is +1.3% vs its 50-day average ($33.46) and +7.7% vs its 200-day average ($31.47).
- 52-week range $25.02β$36.45; today's close sits at 78% of that range, 7.0% below the 52-week high.
Oct 5, 2026 β GRN ends flat (+0.1%) to $33.48
- Closed at $33.48, +0.10% vs the prior close of $33.45. Day range $33.22β$33.48, opened at $33.22.
- Volume was 200 shares, 0.5x its 50-day average of 426 β lighter than usual.
- Price is +0.1% vs its 50-day average ($33.44) and +6.4% vs its 200-day average ($31.47).
- 52-week range $25.02β$36.45; today's close sits at 74% of that range, 8.1% below the 52-week high.
Oct 2, 2026 β GRN dips 2.2% to $33.45 on 3.8x normal volume
- Closed at $33.45, -2.22% vs the prior close of $34.21. Day range $33.38β$33.58, opened at $33.56.
- Volume was 1.80K shares, 3.8x its 50-day average of 470 β unusually heavy trading.
- Price is +0.1% vs its 50-day average ($33.43) and +6.3% vs its 200-day average ($31.47).
- 52-week range $25.02β$36.45; today's close sits at 74% of that range, 8.2% below the 52-week high.
GRN latest news & SEC filings
Every SEC filing by or about GRN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 19, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 19, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 19, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 19, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form FWP β Free writing prospectus (offering marketing material)
Free writing prospectus (offering marketing material)
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 16, 2026 Β· Form 424B2 β Prospectus for a securities offering
Prospectus for a securities offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade GRN
- How much it moves: over the last 20 sessions the average daily move was 0.88% (largest 2.2%). That is a relatively calm stock.
- Liquidity: about 705 shares (β$24.20K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $34.31 vs a range of $25.02β$36.45 (81% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 24, 2026; 6-K Jul 28, 2026; 6-K Jul 28, 2026.
- Listing: NYSE Β· industry: Commercial Banks, NEC.
GRN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 34.00 | 34.31 | 34.31 | 34.31 | 606 |
| Oct 15, 2026 | 34.42 | 34.42 | 34.42 | 34.42 | 100 |
| Oct 14, 2026 | 34.81 | 34.81 | 34.79 | 34.79 | 300 |
| Oct 13, 2026 | 35.32 | 35.42 | 35.32 | 35.32 | 300 |
| Oct 12, 2026 | 35.16 | 35.16 | 35.16 | 35.16 | 100 |
| Oct 9, 2026 | 34.72 | 34.88 | 34.72 | 34.88 | 300 |
| Oct 8, 2026 | 34.79 | 34.81 | 34.79 | 34.81 | 300 |
| Oct 7, 2026 | 34.26 | 34.26 | 34.26 | 34.26 | 100 |
| Oct 6, 2026 | 33.81 | 33.93 | 33.79 | 33.90 | 5.10K |
| Oct 5, 2026 | 33.22 | 33.48 | 33.22 | 33.48 | 200 |
| Oct 2, 2026 | 33.56 | 33.58 | 33.38 | 33.45 | 1.80K |
| Oct 1, 2026 | 34.21 | 34.21 | 34.21 | 34.21 | 100 |
| Sep 30, 2026 | 33.99 | 33.99 | 33.99 | 33.99 | 100 |
| Sep 29, 2026 | 34.38 | 34.38 | 34.38 | 34.38 | 100 |
| Sep 28, 2026 | 34.47 | 34.47 | 34.47 | 34.47 | 100 |
| Sep 25, 2026 | 34.79 | 34.79 | 34.79 | 34.79 | 100 |
| Sep 24, 2026 | 34.70 | 34.70 | 34.70 | 34.70 | 100 |
| Sep 23, 2026 | 34.24 | 34.26 | 33.90 | 34.26 | 4.00K |
| Sep 22, 2026 | 34.88 | 34.88 | 34.88 | 34.88 | 200 |
| Sep 21, 2026 | 34.69 | 34.69 | 34.69 | 34.69 | 100 |
About Barclays Bank
Barclays Bank (GRN) is listed on the NYSE and classified by the SEC under βCommercial Banks, NECβ. Its business address is in LONDON, United Kingdom. State of incorporation: United Kingdom. Fiscal year ends December 31. SEC CIK 312070.
GRN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
GRN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
GRN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Commercial Banks, NEC
Toronto Dominion Bank (TD)Hdfc Bank (HDB)Royal Bank Of Canada (RY)Canadian Imperial Bank Of Commerce (CM)Icici Bank (IBN)Barclays (BCS)Banco Santander (SAN)Credicorp (BAP)Bank Of Montreal (BMO)Lloyds Banking (LYG)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on GRN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.